Vol 3, No 1 (2019): ARxCH
Articles
Overview of Selected Novel Drugs Approved in 2018
Madison Donnelly & Shawn Hodge |
Breakthrough Therapy Designation Awarded to Crisanlizumab, a New Treatment Option for Sickle Cell Disease
Cassandra Kuhn & Olivia Reiber |
The Watchman Device: An Alternative Treatment in Atrial Fibrillation
Anastasia Palmer, Ahmned Mohamed, & Shiader Thao |
Benefits and Risk of Aspirin as Primary Prevention of Cardiovascular Disease
Grant Morgan & Thomas Brown |